Genotyping cytomegalovirus UL97 mutations by high-resolution melting analysis with unlabeled probe

Archives of Virology

Volumn 157, Issue 3, 2012, Pages 475-481

  Zhao, Xiao Tao ^a   Zhou, Dan Qiu ^b   Wu, Shuai ^c   Chen, Yue Wen ^c   Shao, Yong ^d,e   Zhang, Jie ^d,e   Xia, Chang Sheng ^a   Wang, Ke Peng ^d   Yang, Hong ^d   Wan, Jun ^d,f   Yu, Bo ^d,e   Zhang, Zheng ^a   Zhang, Wei ^c,d  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b FUDAN UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

^d Biomedical Research Institute   (China)

^e PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^f HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 84857799256     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-011-1173-y     Document Type: Article

References (46)

1. Baldanti F, Underwood MR, Talarico CL, Simoncini L, Sarasini A, Biron KK, Gerna G (1998) The Cys607-> Tyr change in the UL97 phosphotransferase confers ganciclovir resistance to two human cytomegalovirus strains recovered from two immunocompromised patients. Antimicrob Agents Chemother 42: 444-446.
2. Baldanti F, Michel D, Simoncini L, Heuschmid M, Zimmermann A, Minisini R, Schaarschmidt P, Schmid T, Gerna G, Mertens T (2002) Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system. Antiviral Res 54: 59-67.
3. Biron KK, Fyfe JA, Stanat SC, Leslie LK, Sorrell JB, Lambe CU, Coen DM (1986) A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate. Proc Natl Acad Sci USA 83: 8769-8773.
4. Boeckh M, Fries B, Nichols WG (2004) Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation. Pediatr Transplant 8(Suppl 5): 19-27.
5. Boeckh M, Ljungman P (2009) How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 113: 5711-5719.
6. Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cerny R, Horsnell T, Hutchison CA 3rd, Kouzarides T, Martignetti JA et al (1990) Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 154: 125-169.
7. Chou S, Erice A, Jordan MC, Vercellotti GM, Michels KR, Talarico CL, Stanat SC, Biron KK (1995) Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis 171: 576-583.
8. Chou S, Guentzel S, Michels KR, Miner RC, Drew WL (1995) Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis 172: 239-242.
9. Chou S (1999) Antiviral drug resistance in human cytomegalovirus. Transpl Infect Dis 1: 105-114.
10. Chou S, Waldemer RH, Senters AE, Michels KS, Kemble GW, Miner RC, Drew WL (2002) Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir. J Infect Dis 185: 162-169.
11. Chrisp P, Clissold SP (1991) Foscarnet: a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 41: 104-129.
12. Cihlar T, Chen MS (1996) Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells. Mol Pharmacol 50: 1502-1510.
13. Dames S, Pattison DC, Bromley LK, Wittwer CT, Voelkerding KV (2007) Unlabeled probes for the detection and typing of herpes simplex virus. Clin Chem 53: 1847-1854.
14. De Leeneer K, Coene I, Poppe B, De Paepe A, Claes K (2009) Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden. J Mol Diagn 11: 415-419.
15. Drew WL, Ives D, Lalezari JP, Crumpacker C, Follansbee SE, Spector SA, Benson CA, Friedberg DN, Hubbard L, Stempien MJ et al (1995) Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS: Syntex Cooperative Oral Ganciclovir Study Group. N Engl J Med 333: 615-620.
16. Drew WL (2007) Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients. Curr Opin Infect Dis 20: 408-411.
17. Erali M, Palais R, Wittwer C (2008) SNP genotyping by unlabeled probe melting analysis. Methods Mol Biol 429: 199-206.
18. Erice A (1999) Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev 12: 286-297.
19. Gerna G, Sarasini A, Percivalle E, Zavattoni M, Baldanti F, Revello MG (1995) Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples. J Clin Microbiol 33: 738-741.
20. Gilbert C, Boivin G (2005) Human cytomegalovirus resistance to antiviral drugs. Antimicrob Agents Chemother 49: 873-883.
21. Habalova V, Klimcakova L, Zidzik J, Tkac I (2009) Rapid and cost effective genotyping method for polymorphisms in PPARG, PPARGC1 and TCF7L2 genes. Mol Cell Probes 23: 52-54.
22. Hanson MN, Preheim LC, Chou S, Talarico CL, Biron KK, Erice A (1995) Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrob Agents Chemother 39: 1204-1205.
23. Kampmann SE, Schindele B, Apelt L, Buhrer C, Garten L, Weizsaecker K, Kruger DH, Ehlers B, Hofmann J (2011) Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection. Med Microbiol Immunol.
24. Landry ML, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, Chou S, Drew WL, Erice A, Gilliam B, Lurain N, Manischewitz J, Miner R, Nokta M, Reichelderfer P, Spector S, Weinberg A, Yen-Lieberman B, Crumpacker C (2000) A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrob Agents Chemother 44: 688-692.
25. Liu JB, Zhang Z (2008) Development of SYBR Green I-based real-time PCR assay for detection of drug resistance mutations in cytomegalovirus. J Virol Methods 149: 129-135.
26. Martin DF, Sierra-Madero J, Walmsley S, Wolitz RA, Macey K, Georgiou P, Robinson CA, Stempien MJ (2002) A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 346: 1119-1126.
27. Michel D, Schaarschmidt P, Wunderlich K, Heuschmid M, Simoncini L, Muhlberger D, Zimmermann A, Pavic I, Mertens T (1998) Functional regions of the human cytomegalovirus protein pUL97 involved in nuclear localization and phosphorylation of ganciclovir and pUL97 itself. J Gen Virol 79(Pt 9): 2105-2112.
28. Michel D, Mertens T (2004) The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host. Biochim Biophys Acta 1697: 169-180.
29. Montgomery J, Wittwer CT, Palais R, Zhou L (2007) Simultaneous mutation scanning and genotyping by high-resolution DNA melting analysis. Nat Protoc 2: 59-66.
30. Noble S, Faulds D (1998) Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs 56: 115-146.
31. Pepin JM, Simon F, Dussault A, Collin G, Dazza MC, Brun-Vezinet F (1992) Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures. J Clin Microbiol 30: 2917-2920.
32. Poulson MD, Wittwer CT (2007) Closed-tube genotyping of apolipoprotein E by isolated-probe PCR with multiple unlabeled probes and high-resolution DNA melting analysis. Biotechniques 43: 87-91.
33. Prix L, Maierl J, Jahn G, Hamprecht K (1998) A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains. J Clin Virol 11: 29-37.
34. Prix L, Hamprecht K, Holzhuter B, Handgretinger R, Klingebiel T, Jahn G (1999) Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child. J Infect Dis 180: 491-495.
35. Ronaghi M, Uhlen M, Nyren P (1998) A sequencing method based on real-time pyrophosphate. Science 281: 363, 365.
36. Schnepf N, Boiteau N, Petit F, Alain S, Sanson-Le Pors MJ, Mazeron MC (2009) Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR. Antiviral Res 81: 64-67.
37. Schreiber A, Harter G, Schubert A, Bunjes D, Mertens T, Michel D (2009) Antiviral treatment of cytomegalovirus infection and resistant strains. Expert Opin Pharmacother 10: 191-209.
38. Sia IG, Patel R (2000) New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev 13: 83-121 table of content.
39. Stanat SC, Reardon JE, Erice A, Jordan MC, Drew WL, Biron KK (1991) Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob Agents Chemother 35: 2191-2197.
40. Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK (1992) A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 359: 85.
41. Sun HY, Wagener MM, Singh N (2008) Prevention of post-transplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review. Am J Transplant 8: 2111-2118.
42. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ (2003) High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 49: 853-860.
43. Yeo AC, Chan KP, Kumarasinghe G, Yap HK (2005) Rapid detection of codon 460 mutations in the UL97 gene of ganciclovir-resistant cytomegalovirus clinical isolates by real-time PCR using molecular beacons. Mol Cell Probes 19: 389-393.
44. Zhou L, Harder TC, Ullmann U, Rautenberg P (1999) Rapid detection by reverse hybridization of mutations in the UL97 gene of human cytomegalovirus conferring resistance to ganciclovir. J Clin Virol 13: 53-59.
45. Zhou L, Myers AN, Vandersteen JG, Wang L, Wittwer CT (2004) Closed-tube genotyping with unlabeled oligonucleotide probes and a saturating DNA dye. Clin Chem 50: 1328-1335.
46. Zhou L, Wang L, Palais R, Pryor R, Wittwer CT (2005) High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution. Clin Chem 51: 1770-1777.